about
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysisSimvastatin is associated with a reduced incidence of dementia and Parkinson's diseaseThe quality of care for adults with epilepsy: an initial glimpse using the QUIET measurePatients' self-report of diseases in the Medicare Health Outcomes Survey based on comparisons with linked survey and medical data from the Veterans Health Administration.Dissemination of methods and results from the veterans health study: final comments and implications for future monitoring strategies within and outside the veterans healthcare system.A web-based nutrition program reduces health care costs in employees with cardiac risk factors: before and after cost analysisPatient-provider language concordance and colorectal cancer screeningComparison of health outcomes for male seniors in the Veterans Health Administration and Medicare Advantage plansStandards for epidemiologic studies and surveillance of epilepsy.Health status among 28,000 women veterans. The VA Women's Health Program Evaluation ProjectAssociation of psychiatric illness and obesity, physical inactivity, and smoking among a national sample of veterans.The risk of incident coronary heart disease among veterans with and without HIV and hepatitis CThe relative health related quality of life of veterans with Parkinson's disease.Monitoring depression care: in search of an accurate quality indicator.Patient-based measures of illness severity in the Veterans Health Study.Choices in the use of ICD-9 codes to identify stroke risk factors can affect the apparent population-level risk factor prevalence and distribution of CHADS2 scoresThe challenges of multimorbidity from the patient perspective.Factors associated with health-related quality of life in chronic spinal cord injuryWhat constitutes high quality of care for adults with epilepsy?Prevalence and predictors of underinsurance among low-income adults.An alternative approach to measuring treatment persistence with antipsychotic agents among patients with schizophrenia in the Veterans Health Administration.Measurement of treatment adherence with antipsychotic agents in patients with schizophreniaPatterns of medication administration from 2001 to 2009 in the treatment of children with acute burn injuries: a multicenter study.Validation of self-reported epilepsy for purposes of community surveillance.The impact of epilepsy on older veterans.Cognitive behavioral therapy and aerobic exercise for Gulf War veterans' illnesses: a randomized controlled trial.Monitoring outcomes for the Medicare Advantage program: methods and application of the VR-12 for evaluation of plans.Rural-urban disparities in health-related quality of life within disease categories of Veterans.Evaluation of health services use following the initiation of risperidone long-acting therapy among schizophrenia patients in the veterans health administration.Updated U.S. population standard for the Veterans RAND 12-item Health Survey (VR-12).A Patient-based severity measure of chronic lung disease: evaluating functional health and predicting health services use.Comprehensive health status assessment of centenarians: results from the 1999 large health survey of veteran enrollees.Do poor health behaviors affect health-related quality of life and healthcare utilization among veterans? The Veterans Health Study.Patient characteristics and the likelihood of initiation on olanzapine or risperidone among patients with schizophrenia.Adjunctive use of atypical antipsychotics and anticholinergic drugs among patients with schizophrenia.Comorbidity assessments based on patient report: results from the Veterans Health Study.Study design and sampling in the Veterans Health Study.Patient characteristics and prescription patterns of atypical antipsychotics among patients with schizophrenia.Mental disorders and mental health treatment among U.S. Department of Veterans Affairs outpatients: the Veterans Health Study.Assessment of functional status, low back disability, and use of diagnostic imaging in patients with low back pain and radiating leg pain.
P50
Q24646726-CE072CAF-42DD-450C-BEC6-BC0595F2553CQ24673755-EB21B5AE-D8FD-4A08-A3EF-D0FA997953F6Q30993847-8E73940D-8489-4728-9002-8EBC560A743DQ31150402-E3059C1C-085C-4391-9257-E4BEC60D51A5Q33258098-13FF9007-AB74-4E2B-9615-DB94EE8BC43BQ33575287-692CBB34-BF97-4D57-8E8A-FA54BF5BCA42Q33698234-3216814D-7203-489E-BB95-957DE1FE7D8CQ33725779-9815D001-C1EC-42BF-9C17-5E7F8653D561Q34214261-3C98632F-AE26-42EF-A6A9-2184077E5DF6Q34803656-98157C84-795D-4961-A9DB-9D0B1AC06AD2Q34981408-B205BA6F-7B66-4376-A2D6-FB6E6BCD704EQ35174850-660931C5-0CEE-47E2-8E3A-4A584BF98039Q35471560-FDE658A3-EFC4-45C1-ABAC-52C0168CA798Q35786856-224947C0-E7CE-46D0-AE86-A1537280E7E7Q36169297-BBF6B0A5-E811-4FB7-9D2C-42C20B205263Q36190269-DBEDB8FF-BF33-4A7F-81A3-DAF57E4650A7Q36293487-9805292E-5D3F-46DE-8A2F-8A3757E4395CQ36538147-DF8179F3-443B-4B46-BFA4-EBDA56BB6FA6Q36967660-43D05DA1-A302-4E42-AF98-82E1E58E1648Q37097301-D410C81D-4D33-4EC7-A174-488E0A4EF11BQ37125756-57899D1F-E0DE-4898-9002-7E1E66C4C23CQ37388468-1A5F63D7-7D32-4136-803E-1E1299CCB680Q37910697-D9083607-2A2A-4EA1-82ED-3886ED767E46Q37970542-443AD54F-C276-41BD-8ABF-2E6321557393Q38398041-14C5B17D-633E-4BFA-B360-ABDEAD6B6892Q39397021-DBE6C4C3-4BB3-41F6-9872-72C22038208BQ39557243-62110531-26D6-418D-BDDA-F6C57587871BQ39761418-83825CE9-A506-4838-9F52-FBFB8A3E4AD5Q39818996-60BDE4F9-851B-4C7D-A183-5A8E38465C2CQ40022260-75A0B408-6E50-4DCF-A327-92CB43D25341Q40286852-474D0D90-6096-4191-811C-898AA5620718Q40416946-E7888A1E-8042-4353-9AB0-33AD0A413A3FQ40418365-5B2B51EA-F724-4126-A8CE-A835EB03C575Q40422597-ED007C68-3E5C-441A-8E5C-5B6FA8ABB939Q40453295-E42D54F6-E288-45F7-B65F-7CA4136C669CQ40492214-DE6746B1-0EF5-4A69-A2C1-3CC752792EE3Q40519122-E09C15A7-A7B0-443C-9C56-8D08DB63AF5BQ40616710-C719F992-88AC-453D-9157-6F5812C48557Q40787008-8E9A7A40-8015-42C3-8C57-01178F56C0D9Q40793434-C129BA0A-F133-4DB2-A147-3E6A503DB24C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Lewis E Kazis
@ast
Lewis E Kazis
@en
Lewis E Kazis
@es
Lewis E Kazis
@sl
type
label
Lewis E Kazis
@ast
Lewis E Kazis
@en
Lewis E Kazis
@es
Lewis E Kazis
@sl
altLabel
Lewis Kazis
@en
prefLabel
Lewis E Kazis
@ast
Lewis E Kazis
@en
Lewis E Kazis
@es
Lewis E Kazis
@sl
P1006
P214
P1006
P106
P21
P214
P31
P496
0000-0003-1800-5849
P734
P735
P7859
viaf-289473731